GORE ® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Conditions:   Stroke;   PFO - Patent Foramen Ovale Intervention:   Device: PFO closure with GORE® CARDIOFORM Septal Occluder Sponsor:   W.L.Gore & Associates Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2019 Category: Research Source Type: clinical trials